CDKN2A and Miyoshi myopathy: This is particularly important as MM is associated with chromosomal loss, deletions in CDKN2A, CDKN2B, and NF213, 14, 15 genes and mutations in BAP1 and CUL1.16 Thus, genomic instability limits the long-term usefulness of commercially available MM cell lines.